Furthermore, combining low-dose hCG with GnRH-a (dual trigger) to induce final oocyte maturation improved the number of oocyte retrieval in poor responders without raising the risk of clinically severe OHSS (9). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.